Global Market Study on High Content Screening: Demand in Toxicity Studies Projected to Soar in the Coming Years


High Content Screening  Market
  • Published On : Mar-2018 |
  • Pages : 125 Pages |
  • Format :

This comprehensive research report on global high content screening market by Persistence Market Research supports the reader by assisting him in slating all possible strategies based on valuable insights in order to maintain the much needed tempo with the changing dynamics of the market in the present scenario as well as few years down the line.

Global outlook in a nutshell

Global high content screening market research study focuses on various opportunities, trends, drivers and restraints across key geographies in the globe. This delivers a global perspective by covering all the key areas presenting a holistic view of the market. This assists the reader to get a detailed understanding about the regions with optimum potential in order to slate investment decisions and expansion strategies. The research study eliminates all the biasness giving a more realistic shape to the market acumen.

Unique research methodology

Credibility of the researched data and statistics lie in the uniqueness of the research methodology which ensures higher accuracy. In-depth assessment of the global high content screening market is underpinned by an extensive research process that includes both secondary and primary research to obtain relevant numbers. The data collected undergoes several funnels of validation and re-examination at each step, as the research progresses. This ensures delivering value with data having higher degree of accuracy. The expert opinions of the market observers and the domain experts is extrapolated and triangulation of these enables the analysts to arrive at a much accurate global market representation.

Complete competitive assessment

The research report on global high content screening market involves a separate section which focuses on the key players and the competition standing in the global market. The section involves the strategies applied by the key players, their product portfolios, their innovations, developments and product evolutions, their area wise spread and future expansion plans, the mergers and acquisitions taken place, the market shares and revenues of these tier players, financials, key personnel, etc. This intelligence dashboard completes with the inclusion of the analysis of the various aspects of the key competition in the market. Competitive assessment has been done in a systematic way to enable the reader to draw necessary conclusions.

Market Segmentation

  • Product Type
    • Cell imaging and analysis equipment
      • HCS instruments
        • High end HCS
        • Mid end HCS
        • Low end HCS
      • Flow Cytometers
    • High content screening consumables
      • Reagents and assay kits
      • Microplates
      • Other consumables
    • High content screening software
    • High content screening services
  • Industry
    • Pharmaceutical and healthcare
    • Biotechnology
    • Educational institutions
    • Independent CRO
    • Government organizations
    • others
  • Application
    • Primary and secondary screening
    • Target identification and validation
    • Toxicity studies
    • Compound profiling
    • Others
  • By Region
    • North America
    • Latin America
    • Western Europe
    • Eastern Europe
    • Asia Pacific excluding Japan(APEJ)
    • Japan
    • Middle East and Africa (MEA)

Actionable Insights – A much needed value addition

The comprehensive research report on global high content screening market provides valuable insights with weighted analysis. Every organization has its own integral research team, which strives to gather sufficient research data of the market. Persistence Market Research aims at doing all the heavy lifting by providing unbiased insights which can be actioned by the research team thus supporting in achieving their research milestones.

The “why” to invest in this study

There are several reasons which reinforce the value of this research report, such as un-biasness in the research data collection, detailed and comprehensive and a weighted segmentation of the entire market, the key trends and developments taking place in the market, statistical analysis reaching maximum accuracy, global market forecasts which gives an idea about the future market scenario based on the current and the past market dynamics and assisting the reader in slating important strategies in order to maintain the right rhythm and overcome the challenges caused by the changing market dynamics to achieve competitive advantage.

Drug discovery has been witnessing increased traction since the past few years. Several pharmaceutical companies are focusing on developing new drugs for treating chronic diseases. High content screening is used in biological research, one of the major areas in drug discovery. Explorative screening is possible with this type of technology that permits large number of experiments to be conducted at a time. Moreover, in combination with RNAi, high content screening is used to detect genes sets that are involved in specific mechanisms, for instance cell division.

Use of high content screening to obtain complex assays is one of the aspects pushing the adoption of the technology. Moreover, cell sorting, cell screening and profiling are gaining high importance among end users. This has spurred the use of high content screening to a large extent. With respect to drug discovery, high content screening offers unique approaches to initiate cell screening specific to a particular disease thus offering enhanced secondary cell analysis. With growth in the drug discovery activities, rising demand for high content screening in the coming years goes without saying. 

Favorable government support for life sciences sector to promote growth of global high content screening market

Since the past few years, governments of various countries, especially emerging economies, have been extending their support to biotechnological and pharmaceutical companies that are actively engaged in cell biology, from an economic standpoint. For instance, Chinese government had invested around US$ 882.5 Mn for 900 technology platforms and drug development projects. Government support to carry out various projects with a view to improve and speed-up the discovery of new drugs has positively influenced the growth of the global high content screening market.

Few other aspects that are pushing the growth of the global high content screening include development of advanced informatics solutions, increasing demand for advanced technologies to carry out cell analysis, increasing demand for advanced systems for effective purification protocols as well as screening, emergence of innovative instruments specifically designed for performing image analysis, development of new drug molecules and increasing demand for advanced imaging of cells with primary focus on cell structure, complex morphological analysis and cell aggregation.

global-high-content-screening-market.jpg

Primary and secondary screening to remain a high growth application area for high content screening

As per this research, the use of high content screening for drug discovery is significant. With advances in high content screening technology, it is being used for secondary and primary screening, especially for diseases with causative molecular targets that are typically unknown. Pharmaceutical companies across the globe are shifting their focus towards compound libraries and assaying. Owing to these factors the adoption of high content screening in primary and secondary screening is expected to rise at a robust rate in the coming years. Additionally, sale of high content screening instruments for primary and secondary screening is anticipated to largely contribute to the growth of the global high content screening market.

Target identification and validation to present significant growth opportunities for high content screening

High content screening has proved efficient in identifying new cell components and also carrying out validations of their functionalities. Target identification and validation offers a base with which identification of molecules that intervene with diseases becomes possible. In addition, high content screening provides spatial information associated with cells during process of target identification and validation. Owing to these benefits, use of high content screening for this application area is expected grow in the coming years.

Company Profiles

  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Olympus Corporation
  • PerkinElmer Inc.
  • Merck Millipore Corporation
  • Danaher Corporation (Molecular Devices)
  • Yokogawa Electric Corporation
  • Sysmex Corporation
  • Thorlabs, Inc.
  • Others.
Back To Top